Pricing Log in Create free account

Biodesix, Inc. (BDSX) vs Exagen Inc. (XGN)

Biodesix, Inc. and Exagen Inc. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $260.7M against $207.4M — 1.3× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against 20.8%. Exagen Inc. has the higher net margin (−26.6% vs −27.0%) and the lower return on invested capital (−68.3% vs −49.6%). Across the 18 metrics below, Biodesix, Inc. leads on 9 and Exagen Inc. on 9.

Valuation

Metric BDSX XGN Diagnostics & Research median
P/E n/m n/m 35.56
P/S 2.37 2.60 4.37
P/B 26.64 15.13 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 2.53 2.60 5.51
Earnings yield (13.40%) (10.59%) (1.89%)
Free cash flow yield (8.37%) (4.10%) (0.15%)

Profitability

Metric BDSX XGN Diagnostics & Research median
Gross margin 82.50% 58.64% 50.89%
Operating margin (20.02%) (18.58%) (8.57%)
Net margin (26.97%) (26.61%) (6.37%)
Free cash flow margin (19.82%) (10.66%) 0.00%
Return on equity (540.01%) (113.82%) (2.92%)
Return on assets (30.33%) (34.19%) (6.71%)
Return on invested capital (49.60%) (68.33%) 0.00%

Growth

Metric BDSX XGN Diagnostics & Research median
Revenue growth (TTM) 34.46% 20.83% 7.69%
EPS growth (last fiscal year) 29.24% (12.05%) 25.92%
Revenue growth, 5-year CAGR 14.20% 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX XGN Diagnostics & Research median
Debt to equity 5.12 2.00 0.11
Current ratio 2.85 3.18 2.02
Net debt to EBITDA (1.36) 0.68 0.70

Dividend

Metric BDSX XGN Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BDSX XGN Diagnostics & Research median
Market cap 260.72m 207.37m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack